Table 2 Percentage of overall conclusion, presented separately for each discipline
From: A systematic review of moral reasons on orphan drug reimbursement
Discipline | Overall assessment regarding special status | ||||
|---|---|---|---|---|---|
For special status | Against special status | Conditionally in favour | Unclear | Total | |
Philosophy/bioethics | 13 (45%) | 4 (14%) | 8 (28%) | 4 (14%) | 29 (100%) |
Clinical medicine | 12 (57%) | 2 (10%) | 6 (29%) | 1 (5%) | 21 (100%) |
Health economics | 17 (35%) | 6 (12%) | 21 (43%) | 5 (10%) | 49 (100%) |
Health policy | 40 (39%) | 11 (11%) | 32 (31%) | 20 (19%) | 103 (100%) |
Law | 6 (67%) | 0 (0%) | 1 (11%) | 2 (22%) | 9 (100%) |
Social sciences | 2 (10%) | 7 (35%) | 10 (50%) | 1 (5%) | 20 (100%) |
Industry (stakeholder) | 2 (50%) | 1 (25%) | 1 (25%) | 0 (0%) | 4 (100%) |
Patients (stakeholder) | 3 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (100%) |
Other | 2 (40%) | 0 (0%) | 3 (60%) | 0 (0%) | 5 (100%) |
Total | 97 (40%) | 31 (13%) | 82 (34%) | 33 (14%) | 243 (100%) |